Insider Transactions in Q3 2022 at Talaris Therapeutics, Inc. (TALS)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2022
|
Michael Zdanowski Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+49.7%
|
-
|
|
Sep 10
2022
|
Scott Requadt |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+11.94%
|
-
|
|
Sep 10
2022
|
Nancy Krieger Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+19.5%
|
-
|
|
Sep 10
2022
|
Mary Kay Fenton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+49.69%
|
-
|
|
Aug 22
2022
|
Suzanne Ildstad Director |
SELL
Open market or private sale
|
Direct |
525,000
-14.56%
|
$1,050,000
$2.8 P/Share
|
|
Jul 29
2022
|
Scott Requadt |
BUY
Open market or private purchase
|
Direct |
39,382
+7.19%
|
$157,528
$4.25 P/Share
|
|
Jul 28
2022
|
Scott Requadt |
BUY
Open market or private purchase
|
Direct |
3,090
+0.65%
|
$12,360
$4.25 P/Share
|
|
Jul 26
2022
|
Scott Requadt |
BUY
Open market or private purchase
|
Direct |
5,528
+1.17%
|
$22,112
$4.24 P/Share
|
|
Jul 25
2022
|
Francois Nader Director |
BUY
Other acquisition or disposition
|
Indirect |
138,500
+26.36%
|
-
|
|
Jul 25
2022
|
Francois Nader Director |
SELL
Other acquisition or disposition
|
Direct |
138,500
-100.0%
|
-
|
|
Jul 22
2022
|
Scott Requadt |
BUY
Open market or private purchase
|
Direct |
9,444
+2.01%
|
$28,332
$3.75 P/Share
|
|
Jul 21
2022
|
Francois Nader Director |
BUY
Open market or private purchase
|
Direct |
36,500
+20.86%
|
$109,500
$3.72 P/Share
|
|
Jul 21
2022
|
Francois Nader Director |
BUY
Other acquisition or disposition
|
Indirect |
248,432
+50.0%
|
-
|
|
Jul 21
2022
|
Francois Nader Director |
SELL
Other acquisition or disposition
|
Indirect |
248,432
-73.9%
|
-
|
|
Jul 20
2022
|
Francois Nader Director |
BUY
Open market or private purchase
|
Direct |
52,000
+33.77%
|
$156,000
$3.62 P/Share
|
|
Jul 19
2022
|
Francois Nader Director |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$150,000
$3.52 P/Share
|